Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Reports: Charles River 1Q | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Financial Reports: Charles River 1Q

Preclinical revenues drop, offset by RMS uptick

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Charles River Laboratories 1Q12

1Q Revenues: $286 million (flat)

1Q Earnings: $26 million (-16%)

Comments: Research Models and Services was up 6% to $183 million, driven by In Vitro and Avian businesses., for its best quarter since 2008. Preclinical Services dropped 9% to $103 million, with lower sales of biopharmaceutical services due to typically slow starts from large biopharma cients.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics